AAR trended towards a benefit in both groups but did not reach statistical significance.
← all excerpts
A novel TLR-8 agonist attenuates nasal symptoms/congestion in both dog and human allergen challenge studies
1
—
—
AAR trended towards a benefit in both groups but did not reach statistical significance.